InsidersTradesSigma
Explore the full record of transactions filed by Koppel Adam, Director. Officer active across 1 companies, notably Dicerna Pharmaceuticals Inc. Cumulatively, 4 disclosures have been recorded. The latest transaction was disclosed on 28 December 2021 (U). Regulator: SEC (Form 4). The full history is openly available.
4 of 4 declarations
Koppel Adam is a Board Member at Dicerna Pharmaceuticals Inc. He plays an important role in the company's leadership, providing his expertise to guide strategic decisions and foster innovation.